WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 96

Legislative bill overview

SB 96 amends Utah's opioid fatality review process, establishing or modifying procedures for how deaths involving opioids are investigated and reviewed by multidisciplinary teams. The bill passed the Utah Senate in early February 2026 and is now in the House for consideration.

Why is this important

Opioid fatality reviews provide critical data on overdose deaths and can identify systemic failures, prescription patterns, and prevention opportunities. Streamlining these reviews helps communities better understand overdose trends and implement targeted harm reduction strategies.

Potential points of contention

  • Privacy and transparency balance: Fatality review processes must balance accessing complete medical/prescription records with protecting individual privacy rights and family concerns
  • Resource allocation: Establishing or expanding review protocols requires funding for trained personnel, coordination across agencies, and ongoing administrative support
  • Implementation variation: Counties or districts may lack capacity to implement standardized review procedures uniformly, creating unequal coverage across the state

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.